mo:re is a biotechnology start-up reducing the time to market for new therapies by replacing animal trials with AI-assisted cultivation of disease models. The Micro-Lab, our platform of a laboratory robot and software, sets a new standard for pre-clinical drug research because new compounds can be tested in a standardised and high-throughput fashion. Our technology enables scaling up experiments without compromising traceability and quality to bridge the gap between PoC and industry experiments.